PA8568501A1 - OXO-AZABICICLIC COMPOUNDS - Google Patents
OXO-AZABICICLIC COMPOUNDSInfo
- Publication number
- PA8568501A1 PA8568501A1 PA20038568501A PA8568501A PA8568501A1 PA 8568501 A1 PA8568501 A1 PA 8568501A1 PA 20038568501 A PA20038568501 A PA 20038568501A PA 8568501 A PA8568501 A PA 8568501A PA 8568501 A1 PA8568501 A1 PA 8568501A1
- Authority
- PA
- Panama
- Prior art keywords
- rent
- inclusive
- whole number
- group
- descriptive memory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
UN COMPUESTO SELECCIONADO DE AQUELLOS DE LA FORMULA (1): EN DONDE: X1,X2 Y X3 REPRESENTAN N O -CR3 EN DONDE R3 ES LO DESCRIPTO EN LA MEMORIA DESCRIPTIVA, G1 REPRESENTA UN GRUPO SELECCIONADO DE AQUELLOS DE LAS FORMULAS (I/A) E (I/B): EN DONDE R4,R5, Y R6 SON LO DEFINIDO ANTERIORMENTE, G2 REPRESENTA UN GRUPO SELECCIONADO DE ENLACE TRIPLE DE CARBONO-CARBONO, -CH=C=CH-, C=O, C=S, S(O)N1 EN DONDE N1 REPRESENTA UN NUMERO ENTERO DE 0 A 2 INCLUSIVE, Y UN GRUPO DE LA FORMULA (I/C): EN DONDE Y1 REPRESENTA O, S, -NH O -N ALQUILO E Y2 REPRESENTA O,S,-NH O -N ALQUILO, N ES UN NUMERO ENTERO DE 0 A 6 INCLUSIVE, Y M ES UN NUMERO ENTERO DE 0 A 7 INCLUSIVE, Z1 REPRESENTA -CR9R10, EN DONDE R9 Y R10 SON LO DEFINIDO EN LA MEMORIA DESCRIPTIVA, A REPRESENTA UN SISTEMA DE ANILLO, R1 REPRESENTA UN GRUPO SELECCIONADO DE H, ALQUILO, ALQUENILO,ALQUINILO, OPTATIVAMENTE SUSTITUIDO Y EL GRUPO DE LA FORMULA (I/D): EN DONDE P,Z2,B,Q Y G2 SON LO DEFINIDO EN LA MEMORIA DESCRIPTIVA Y OPTATIVAMENTE, SUS ISOMEROS OPTICOS, N-OXIDOS Y SALES DE ELLOS CON EL ACIDO O BASE FARMACEUTICAMENTE ACEPTABLE, Y PRODUCTOS MEDICINALES QUE CONTIENEN LOS MISMOS SON UTILES COMO INHIBIDORES ESPECIFICOS DE LA METALOPROTEASA DE LA MATRIZ DE TIPO 13.A SELECTED COMPOUND OF THOSE OF THE FORMULA (1): WHERE: X1, X2 AND X3 REPRESENT NO -CR3 WHERE R3 IS WHAT IS DESCRIBED IN THE DESCRIPTIVE MEMORY, G1 REPRESENTS A SELECTED GROUP OF THOSE OF THE FORMULAS (I / A) E (I / B): WHERE R4, R5, AND R6 ARE THE DEFINED ABOVE, G2 REPRESENTS A SELECTED GROUP OF CARBON-CARBON TRIPLE LINK, -CH = C = CH-, C = O, C = S, S (O) N1 WHERE N1 REPRESENTS A WHOLE NUMBER OF 0 TO 2 INCLUSIVE, AND A FORMULA GROUP (I / C): WHERE Y1 REPRESENTS OR, S, -NH OR -N RENT AND Y2 REPRESENTS OR, S, -NH OR -N RENT, N IS A WHOLE NUMBER OF 0 TO 6 INCLUSIVE, YM IS A WHOLE NUMBER OF 0 TO 7 INCLUSIVE, Z1 REPRESENTS -CR9R10, WHERE R9 AND R10 ARE THE DEFINED IN THE DESCRIPTIVE MEMORY, A REPRESENTS A RING SYSTEM, R1 REPRESENTS A SELECTED GROUP OF H, RENT, RENT, RENT, OPTIONALLY REPLACED AND THE FORMULA GROUP (I / D): WHERE P, Z2, B, Q AND G2 ARE THE DEFINED IN THE DESCRIPTIVE MEMORY AND OPTIONALLY, YOUR OPTICAL ISOMERS, N-OXIDES AND SALTS OF THEM WITH THE PHARMACEUTICALLY ACCEPTABLE ACID OR BASE, AND MEDICINAL PRODUCTS CONTAINING THE SAME ARE USEFUL AS SPECIFIC INHIBITORS OF THE METALOPROTEASE OF TYPE MATRIX 13.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2002/003240 WO2003076416A1 (en) | 2002-03-08 | 2002-03-08 | Oxo azabicyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8568501A1 true PA8568501A1 (en) | 2003-12-19 |
Family
ID=27798761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20038568501A PA8568501A1 (en) | 2002-03-08 | 2003-03-06 | OXO-AZABICICLIC COMPOUNDS |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1492775A2 (en) |
| JP (1) | JP2005526070A (en) |
| KR (1) | KR20040095270A (en) |
| CN (1) | CN1738806A (en) |
| AP (1) | AP2004003125A0 (en) |
| AR (1) | AR039562A1 (en) |
| AU (2) | AU2002249275A1 (en) |
| BR (1) | BR0308280A (en) |
| CA (1) | CA2478706A1 (en) |
| CO (1) | CO5601020A2 (en) |
| EA (1) | EA200401053A1 (en) |
| EC (1) | ECSP045278A (en) |
| IL (1) | IL163818A0 (en) |
| IS (1) | IS7414A (en) |
| MA (1) | MA27183A1 (en) |
| MX (1) | MXPA04008681A (en) |
| NO (1) | NO20044041L (en) |
| OA (1) | OA12782A (en) |
| PA (1) | PA8568501A1 (en) |
| PE (1) | PE20031018A1 (en) |
| PL (1) | PL372622A1 (en) |
| SV (1) | SV2003001495A (en) |
| TN (1) | TNSN04169A1 (en) |
| UY (1) | UY27700A1 (en) |
| WO (2) | WO2003076416A1 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8539501A1 (en) | 2001-02-14 | 2002-09-30 | Warner Lambert Co | TRIAZOLO COMPOUNDS AS MMP INHIBITORS |
| US6962922B2 (en) | 2001-10-12 | 2005-11-08 | Warner-Lambert Company Llc | Alkynylated quinazoline compounds |
| US6894057B2 (en) | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| AU2003253150A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Chromone derivatives as matrix metalloproteinase inhibitors |
| JP2006501215A (en) | 2002-08-13 | 2006-01-12 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Monocyclic derivatives as matrix metalloproteinase inhibitors |
| WO2004014378A1 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors |
| WO2004014375A2 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Fused bicyclic metalloproteinase inhibitors |
| PA8578101A1 (en) | 2002-08-13 | 2004-05-07 | Warner Lambert Co | HETEROBIARILO DERIVATIVES AS METALOPROTEINASE IN MATRIX INHIBITORS |
| AU2003250470A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidinone fused bicyclic metalloproteinase inhibitors |
| WO2004014384A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| AU2003250471A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| AU2003253186A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors |
| BR0313724A (en) | 2002-08-13 | 2005-06-28 | Warner Lambert Co | Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
| WO2005016926A1 (en) * | 2003-08-19 | 2005-02-24 | Warner-Lambert Company Llc | Pyrido [3,4-d] pyrimidine derivatives as matrix metalloproteinase-13 inhibitors |
| DE10360835A1 (en) * | 2003-12-23 | 2005-07-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| MXPA06012333A (en) * | 2004-04-30 | 2007-01-17 | Takeda Pharmaceutical | Heterocyclic amide compound and use thereof as an mmp-13 inhibitor. |
| CN101001845A (en) * | 2004-06-15 | 2007-07-18 | 阿斯利康(瑞典)有限公司 | Substituted quinazolones as anti-cancer agents. |
| RU2009112397A (en) | 2006-10-05 | 2010-10-10 | Си Ви ТЕРАПЬЮТИКС, ИНК (US) | BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROIL COA DESATURASES INHIBITORS |
| WO2012052451A1 (en) | 2010-10-18 | 2012-04-26 | Merz Pharma Gmbh & Co. Kgaa | Metabotropic glutamate receptor modulators |
| CN103524431B (en) * | 2013-09-24 | 2016-01-13 | 西安交通大学 | 3-benzyl-4-quianzolinones and synthetic method thereof and application |
| JO3512B1 (en) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | Quinoxaline derivatives useful as fgfr kinase modulators |
| CN108137546B (en) | 2015-09-23 | 2021-07-27 | 詹森药业有限公司 | Bis-heteroaryl substituted 1, 4-benzodiazepine compounds and their use for the treatment of cancer |
| JP6898919B2 (en) | 2015-09-23 | 2021-07-07 | ヤンセン ファーマシューティカ エヌ．ベー． | New compound |
| FR3046793B1 (en) * | 2016-01-14 | 2018-01-05 | Les Laboratoires Servier | NOVEL PHOSPHINAN DERIVATIVES AND AZAPHOSPHINANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0946095A1 (en) * | 1996-12-17 | 1999-10-06 | E.I. Du Pont De Nemours And Company | Fungicidal quinazolinones |
| PA8539401A1 (en) * | 2001-02-14 | 2002-10-28 | Warner Lambert Co | QUINAZOLINAS AS INHIBITORS OF MMP-13 |
| PA8539301A1 (en) * | 2001-02-14 | 2002-09-30 | Warner Lambert Co | INHIBITORS OF THE METALOPROTEINASE OF THE MATRIX |
-
2002
- 2002-03-08 AU AU2002249275A patent/AU2002249275A1/en not_active Abandoned
- 2002-03-08 WO PCT/EP2002/003240 patent/WO2003076416A1/en not_active Application Discontinuation
-
2003
- 2003-03-04 SV SV2003001495A patent/SV2003001495A/en not_active Application Discontinuation
- 2003-03-06 BR BR0308280-6A patent/BR0308280A/en not_active IP Right Cessation
- 2003-03-06 CN CNA038048752A patent/CN1738806A/en active Pending
- 2003-03-06 EP EP03708181A patent/EP1492775A2/en not_active Withdrawn
- 2003-03-06 OA OA1200400234A patent/OA12782A/en unknown
- 2003-03-06 AU AU2003212307A patent/AU2003212307A1/en not_active Abandoned
- 2003-03-06 EA EA200401053A patent/EA200401053A1/en unknown
- 2003-03-06 AP APAP/P/2004/003125A patent/AP2004003125A0/en unknown
- 2003-03-06 PE PE2003000218A patent/PE20031018A1/en not_active Application Discontinuation
- 2003-03-06 PL PL03372622A patent/PL372622A1/en not_active Application Discontinuation
- 2003-03-06 KR KR10-2004-7013994A patent/KR20040095270A/en not_active Application Discontinuation
- 2003-03-06 PA PA20038568501A patent/PA8568501A1/en unknown
- 2003-03-06 CA CA002478706A patent/CA2478706A1/en not_active Abandoned
- 2003-03-06 MX MXPA04008681A patent/MXPA04008681A/en unknown
- 2003-03-06 WO PCT/EP2003/002277 patent/WO2003076417A2/en not_active Application Discontinuation
- 2003-03-06 UY UY27700A patent/UY27700A1/en not_active Application Discontinuation
- 2003-03-06 IL IL16381803A patent/IL163818A0/en unknown
- 2003-03-06 AR ARP030100749A patent/AR039562A1/en not_active Application Discontinuation
- 2003-03-06 JP JP2003574636A patent/JP2005526070A/en not_active Withdrawn
-
2004
- 2004-08-19 IS IS7414A patent/IS7414A/en unknown
- 2004-08-25 CO CO04082792A patent/CO5601020A2/en not_active Application Discontinuation
- 2004-08-31 MA MA27842A patent/MA27183A1/en unknown
- 2004-09-03 EC EC2004005278A patent/ECSP045278A/en unknown
- 2004-09-03 TN TNP2004000169A patent/TNSN04169A1/en unknown
- 2004-09-24 NO NO20044041A patent/NO20044041L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5601020A2 (en) | 2006-01-31 |
| TNSN04169A1 (en) | 2007-03-12 |
| WO2003076417A3 (en) | 2003-11-13 |
| AU2003212307A1 (en) | 2003-09-22 |
| JP2005526070A (en) | 2005-09-02 |
| CN1738806A (en) | 2006-02-22 |
| CA2478706A1 (en) | 2003-09-18 |
| EP1492775A2 (en) | 2005-01-05 |
| AP2004003125A0 (en) | 2004-09-30 |
| SV2003001495A (en) | 2003-11-04 |
| EA200401053A1 (en) | 2005-04-28 |
| MXPA04008681A (en) | 2004-12-06 |
| AR039562A1 (en) | 2005-02-23 |
| WO2003076417A2 (en) | 2003-09-18 |
| OA12782A (en) | 2006-07-10 |
| NO20044041L (en) | 2004-10-07 |
| PL372622A1 (en) | 2005-07-25 |
| BR0308280A (en) | 2004-12-28 |
| ECSP045278A (en) | 2004-10-26 |
| UY27700A1 (en) | 2003-10-31 |
| IL163818A0 (en) | 2005-12-18 |
| MA27183A1 (en) | 2005-01-03 |
| AU2002249275A1 (en) | 2003-09-22 |
| IS7414A (en) | 2004-08-19 |
| PE20031018A1 (en) | 2004-01-09 |
| KR20040095270A (en) | 2004-11-12 |
| WO2003076416A1 (en) | 2003-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8568501A1 (en) | OXO-AZABICICLIC COMPOUNDS | |
| ES2190396T3 (en) | NEW AMINO-TRIAZOL COMPOUNDS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| SV2003000876A (en) | QUINAZOLINAS AS INHIBITORS OF MMP-13 | |
| PA8582801A1 (en) | NEW SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE | |
| AR008377A1 (en) | A COMPOUND DERIVED FROM 3-AROYLBENCIL-PIRIDAZINONE, A PARTICULAR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY OR AUTOIMMUNE DISEASES CONTAINING SUCH A COMPOUND | |
| PA8539501A1 (en) | TRIAZOLO COMPOUNDS AS MMP INHIBITORS | |
| NO20040680D0 (en) | New dihydropterinone processes for their preparation and their use as a drug | |
| AR245447A1 (en) | Substituted pyrimidines, their synthesis and compositions containing them, their use in medicine and intermediates for making them | |
| MX9300786A (en) | HYPOLIPIDAEMIC COMPOUNDS. | |
| UY26505A1 (en) | SUBSTITUTED PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| CO4810375A1 (en) | DERIVATIVES OF 9-AMINO-3-KETO Erythromycin | |
| AR009938A1 (en) | NEW ARILGLYCINAMIDE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
| UY27853A1 (en) | DIFENILAZETIDINONAS REPLACED IN ACID GROUP, PROCEDURE FOR PREPARATION, MEDICINES THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE. | |
| ES2183492T3 (en) | NEW NITRON DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ES2069281T3 (en) | DERIVATIVE FROM FENANTRENO. | |
| PA8589801A1 (en) | AMINOALCOXYINDOLS | |
| UY26501A1 (en) | SUBSTITUTED PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| ES2032752T3 (en) | PREPARATION PROCEDURE FOR 1-BENZENOSULFONYL-2-OXO-5-ALCOXY-PIRROLIDINE DERIVATIVES. | |
| ES2029879T3 (en) | PROCEDURE FOR PRODUCING SUBSTITUTED AMINE DERIVATIVES. | |
| ES2172023T3 (en) | NEW SUBSTITUTED TETRAHYDRA-PYRIDINIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| YU5896A (en) | Use of amides phenylcyclohexylcarbonic acid, single amides of phenylcyclohexylcarbonic acid, process for their production and medicaments containing them | |
| AR027578A1 (en) | INDANO DERIVATIVES | |
| ES2157541T3 (en) | DERIVATIVES OF N-BENCIL-PIPERAZINA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| DOP2003000603A (en) | OXO-AZABICICLIC COMPOUNDS | |
| ES2172436B1 (en) | INDOLILPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALERGIC AGENTS. |